Invention Grant
US08455627B2 Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa
有权
血小板整合素受体GPIIb / IIIa活化状态的人抗体
- Patent Title: Human antibody specific for activated state of platelet integrin receptor GPIIb/IIIa
- Patent Title (中): 血小板整合素受体GPIIb / IIIa活化状态的人抗体
-
Application No.: US12877003Application Date: 2010-09-07
-
Publication No.: US08455627B2Publication Date: 2013-06-04
- Inventor: Claudia Linhard , Stefan Knackmuss , Melvyn Little , Karlheinz Peter , Peter Roettgen , Meike Schwarz
- Applicant: Claudia Linhard , Stefan Knackmuss , Melvyn Little , Karlheinz Peter , Peter Roettgen , Meike Schwarz
- Applicant Address: DE Heidelberg
- Assignee: Affimed Therapeutics, AG
- Current Assignee: Affimed Therapeutics, AG
- Current Assignee Address: DE Heidelberg
- Agency: Perkins Coie LLP.
- Agent Patrick Morris; Viola T. Kung
- Priority: EP01123851 20011005
- Main IPC: C07K16/28
- IPC: C07K16/28
Abstract:
The present invention is directed to an antibody or derivative thereof of human origin for inhibiting platelet aggregation, characterized in that it is effective by substantially exclusive binding to the activated state of platelet integrin receptor GPIIb/IIIa.
Public/Granted literature
- US20110165175A1 ANTIBODY OF HUMAN ORIGIN FOR INHIBITING THROMBOCYTES AGGREGATION Public/Granted day:2011-07-07
Information query
